Moderna, Inc. MRNA
NASDAQ
Recommendation
Dividend Power Score
Day's Range
$229.69$245.37
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.37B | 2.07B | 2.09B | 1.82B | 2.11B |
| Total Other Revenue | 160.00M | 163.00M | 140.00M | 125.00M | 121.00M |
| Total Revenue | 2.53B | 2.23B | 2.23B | 1.94B | 2.23B |
| Cost of Revenue | 3.59B | 3.70B | 3.78B | 4.00B | 4.63B |
| Gross Profit | -1.06B | -1.47B | -1.56B | -2.06B | -2.40B |
| SG&A Expenses | 979.00M | 965.00M | 979.00M | 1.02B | 1.06B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.57B | 4.66B | 4.76B | 5.02B | 5.70B |
| Operating Income | -2.04B | -2.44B | -2.53B | -3.07B | -3.46B |
| Income Before Tax | -2.73B | -3.09B | -3.14B | -2.77B | -3.15B |
| Income Tax Expenses | 60.00M | 64.00M | 56.00M | 54.00M | -37.00M |
| Earnings from Continuing Operations | -2.79K | -3.15K | -3.19K | -2.82K | -3.12K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.79B | -3.15B | -3.19B | -2.82B | -3.12B |
| EBIT | -2.04B | -2.44B | -2.53B | -3.07B | -3.46B |
| EBITDA | -1.78B | -2.20B | -2.30B | -2.86B | -3.26B |
| EPS Basic | -7.07 | -7.98 | -8.15 | -7.26 | -8.06 |
| Normalized Basic EPS | -2.91 | -3.49 | -3.61 | -4.44 | -5.08 |
| EPS Diluted | -7.09 | -7.98 | -8.15 | -7.26 | -8.07 |
| Normalized Diluted EPS | -2.93 | -3.49 | -3.61 | -4.44 | -5.08 |
| Average Basic Shares Outstanding | 1.59B | 1.58B | 1.57B | 1.56B | 1.55B |
| Average Diluted Shares Outstanding | 1.62B | 1.58B | 1.57B | 1.56B | 1.55B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |